Logo main
  • PROMOTE YOUR VENTURE
    • Startup listings
    • IP & Tech listings
  • GET HELP
    • Search questions
    • Post projects
    • Search expert directory
  • RESOURCES
    • Document Center
    • Search for patents
    • Expert articles / posts
  • NEWS & EVENTS
    • Tech & IP News
  • My Account
  • Sign in
  • FOR PROFESSIONALS
  • Icon jp

Patents

68,020 found
SEE ALL IP TYPES
PATENTFIELD SEARCH
UPLOAD IP
Granted

MRI imaging-scanning

MRI imaging-scanning

Granted

Cell-calcification inhibito...

Cell-calcification inhibitory protein

Granted

AAV

Adeno-associated virus (AAV) is a small virus which infects humans and some other primate species. AAV is not currently known to cause disease and consequently the virus causes a very mild immune r...

Granted

PI3K lipid kinase inhibitors

As wortmannin and LY294002 are broad inhibitors against PI 3-kinases and a number of unrelated proteins at higher concentrations they are too toxic to be used as therapeutics.[citation needed] A nu...

Granted

Chimeric proteins for cell ...

Chimeric proteins for cell targeting

Granted

Genetic constructs

Genetic constructs

Granted

Fc gamma RIIA

Fc gamma RIIA

Pending

Protease inhibitors

Protease inhibitors (PIs) are a class of antiviral drugs that are widely used to treat HIV/AIDS and hepatitis caused by hepatitis C virus. Protease inhibitors prevent viral replication by selective...

Granted

Biphenyl compounds

Substituted biphenyls can be prepared synthetically by various coupling reactions including the Suzuki reaction and the Ullmann reaction and have many uses. Polychlorinated biphenyls were once used...

Granted

Thyroid cancer

Thyroid cancer is a cancer originating from follicular or parafollicular thyroid cells. The most effective management of aggressive thyroid cancers is surgical removal of thyroid gland (thyroide...

Pending

Enhanced chemiluminescence

Enhanced chemiluminescence is a common technique for a variety of detection assays in biology. A horseradish peroxidase enzyme (HRP) is tethered to an antibody that specifically recognizes the mole...

Granted

Antagonist antibodies again...

Antagonist antibodies against GDF-8

Granted

Determining drug responsive...

Determining drug responsiveness

Granted

ErbB interface peptidomimetics

ErbB interface peptidomimetics

Granted

RNA containing modified nuc...

RNA containing modified nucleosides

Granted

Cardiac stem cell delivery

Cardiac stem cell delivery

Granted

Determining drug responsive...

Determining drug responsiveness

Granted

Polyvalent viral vectors

Polyvalent viral vectors

Granted

Simian adenovirus

Simian adenovirus

Granted

HSV vaccines

Various vaccine candidates have been developed, the first ones in the 1920s, but none have been successful to date.[1] Due to the genetic similarity of both herpes simplex virus types (HSV-1 and...

  • First
  • Prev
  • …
  • 2151
  • 2152
  • 2153
  • 2154
  • 2155
  • 2156
  • 2157
  • 2158
  • 2159
  • …
  • Next
  • Last
Your one-stop shop for innovation and intellectual property Join us today

About us

IP Nexus is an IP commercialisation company that builds successful startup companies by collaborating with inventors, universities and research institutes to identify high-potential inventions at an early stage and provide the commercial direction, fundraising expertise and management talent necessary to build outstanding companies. IP Nexus has particular focus and expertise in Asia.

Disclaimer

IP Nexus, including the Ask an Expert and Services Marketplace, is an interactive online service that makes it faster and easier for businesses to find and hire legal help solely based on their search preferences. We are not a law firm, do not provide any legal services, legal advice or lawyer referral services and do not provide or participate in any legal representation.

Content

  • PRICING
  • FREQUENTLY ASKED QUESTIONS
  • IP PROTECTION
  • IP TYPES
  • IP CLAIMS
  • OUR TEAM
  • STARTUPS
  • CONTACT US
  • BRAND ASSETS
  • TERM OF USE
  • PRIVACY POLICY
  • SEARCH PATENTS ON PATENTFIELD

Newsletter

Subscribe

Languages

Icon jp

Logo gray © 2025 IP Nexus. All Rights Reserved.

Report content

      Contact form